4.7 Article

Novel strategy for accurate tumor labeling: endogenous metabolic imaging through metabolic probes

Journal

SCIENCE CHINA-CHEMISTRY
Volume 65, Issue 12, Pages 2517-2527

Publisher

SCIENCE PRESS
DOI: 10.1007/s11426-022-1372-y

Keywords

molecular probe; metabolic imaging; tumor labeling; GSH

Funding

  1. National Natural Science Foundation of China [21705102, 21775096, 22074084]
  2. Basic Research Program of Shanxi Province [20210302123430]

Ask authors/readers for more resources

In this study, a metabolic probe MB-C was developed to label tumors based on metabolic differences, allowing for precise visualization.
Altered metabolism has long been recognized as a central hallmark of cancer; however, in the fluorescence imaging field, few studies have been conducted to label tumors by exploiting metabolic differences between cancer cells and normal cells. In this work, we successfully developed a metabolic probe MB-C for specific imaging of glutathione (GSH) dynamic metabolic pathways. GSH was endogenously metabolized to produce SO(2)via Na2S2O3 and thiosulfate sulfurtransferase, equilibrating with sulfites/bisulfites. MB-C was allowed to be activated by GSH along with multi-fluorescence emission increased in red and green channels and further sequence-response metabolites (SO2) of GSH in significant fluorescence ratio change of red and green channels. Furthermore, such evident fluorescence ratio changes could be used to distinguish cancer cells from normal cells and identify tumor and normal tissues. Therefore, GSH metabolic imaging was successfully applied to accurately label tumors, which provides a new idea and practical case for the precise visualization of malignant tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available